Meng Li
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Safety and Efficiency Study of Pioglitazone in Combination With Imatinib Mesylate to Treat Chronic Myelogenous Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Phase 2 | 2016-02-01 |